DelveInsight's Underactive Bladder Syndrome Market Insights report includes a comprehensive understanding of current ...
West Tennessee Healthcare is pleased to announce a new treatment option for people living with urge urinary incontinence (UUI ...
Saudi Arabia's Food and Drug Authority grants conditional approval for Anktiva, a new cancer therapy for advanced lung and ...
The Saudi Food and Drug Authority (SFDA) has granted conditional approval for Anktiva, a groundbreaking cancer therapy, for ...
Urology departments in England and Wales have reported seeing an increase in the number of 16- to 24-year-olds being admitted ...
Saudi Arabia leads the way as the first country to grant conditional approval for Anktiva, a groundbreaking treatment for ...
Saudi Gazette on MSN
Saudi: SFDA approves registration of 'Anktiva' for treatment of bladder and lung cancer
The SFDA is the first regulatory authority globally to grant conditional approval for this medication for the treatment of NSCLC ...
The underactive bladder syndrome market is expected to grow steadily, driven by an aging global population and rising prevalence of neurogenic and chronic conditions affecting bladder function.
Urology departments in England and Wales have seen an increase in bladder inflammation among 16 to 24-year-olds ...
Ketamine users can develop tolerance to the drug quickly, needing higher doses to get the same effects. This is probably due to the body and brain adapting to become more efficient at breaking down ...
I'm trained to treat conditions I used to see mainly in older patients - but now it's all teenagers and people in their early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback